Back
ResMed 10K Form
Buy
57
RMD
ResMed
Last Price:
$224.10
Seasonality Move:
5.7%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-10-27 | 10Q | RMD/ResMed Quarterly |
| 2023-04-28 | 10Q | RMD/ResMed Quarterly |
| 2023-01-27 | 10Q | RMD/ResMed Quarterly |
| 2022-10-28 | 10Q | RMD/ResMed Quarterly |
| 2022-04-29 | 10Q | RMD/ResMed Quarterly |
| 2022-01-28 | 10Q | RMD/ResMed Quarterly |
Receive RMD News And Ratings
See the #1 stock for the next 7 days that we like better than RMD
RMD Financial Statistics
Sales & Book Value
| Annual Sales: | $4.7B |
|---|---|
| Cash Flow: | $285.2M |
| Price / Cash Flow: | 23.9 |
| Annual Sales: | $35.77 |
| Price / Book: | 6.27 |
Profitability
| EPS (TTM): | 8.47000 |
|---|---|
| Net Income (TTM): | $1.2B |
| Gross Margin: | $2.7B |
| Return on Equity: | 25.56% |
| Return on Assets: | 17.86% |
ResMed Earnings Forecast
Key ResMed Financial Ratios
-
The Gross Profit Margin over the past 32 years for RMD is 56.67%.
-
The Selling, General & Administrative Expenses for RMD have been equal to 19.57% of Gross Profit Margin.
-
The Research & Development expenses have been 6.56% of Revenue.
-
The Interest Expense is 4.48% of Operating Income.
-
The Net Earning history of RMD is 21.79% of Total Revenues.
-
Per Share Earnings over the last 32 years have been positive in 25 years.
ResMed Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | RMD |
| CUSIP: | 761152 |
| Website: | resmed.com |
Debt
| Debt-to-Equity Ratio: | 0.13 |
|---|---|
| Current Ratio: | 3.33 |
| Quick Ratio: | 1.74 |
Price-to-Earnings
| Trailing P/E Ratio: | 32.39 |
|---|---|
| Forward P/E Ratio: | 21.54 |